Ying-Yong Zhao (Yingyong Zhao)

Scopus Author ID Scopus Author ID Scopus Author ID Loop profile ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Venues

British journal of pharmacology

Signal transduction and targeted therapy

Therapeutic advances in chronic disease

Cellular and molecular life sciences : CMLS

Bentham Science Publishers Ltd

University of California Irvine School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Bentham Science Publishers Ltd

United Arab Emirates

Associate Editor :: Current Metabolomics and Systems Biology

S Karger Publishers Inc

United States

Editorial Board Member :: American Journal of Nephrology

Cell Med Press

United States

Editorial Board Member :: Reactive Oxygen Species

Springer Nature Jul 01 2019

Luxembourg

Senior Editorial Board Member :: Scientific Reports

Frontiers in Medicine Jul 17 2018

Eswatini

Associate Editor :: Frontiers Media S.A.

Pharmacognosy Magazine Feb 01 2018

India

Editor :: Wolters Kluwer India Pvt Ltd

Northwest University May 01 2012

China

Professor

Springer Nature Mar 01 2017

Luxembourg

Editorial Board Member :: Scientific Reports

University of California Irvine School of Medicine May 01 2014 - Dec 31 2015

United States

Researcher :: School of Medicine

Education History

University of California Irvine School of Medicine May 01 2014 - Dec 31 2015

United States

PHD :: School of Medicine

Fourth Military Medical University Jul 01 2012 - Mar 31 2015

China

PHD :: School of Pharmacy

Northwest University Jul 01 2010 - Apr 30 2012

China

PHD :: Faculty of Life Science and Medicine

Publications

Yan-Ni Wang, Xiao-Jun Li, Wen-Feng Wang, Liang Zou, Hua Miao, Ying-Yong Zhao
Geniposidic Acid Attenuates Chronic Tubulointerstitial Nephropathy Through Regulation of the NF-ƙB/Nrf2 Pathway Via Aryl Hydrocarbon Receptor Signaling. Phytotherapy research : PTR (2024)
Hua Miao, Fei Liu, Yan-Ni Wang, Xiao-Yong Yu, Shougang Zhuang, Yan Guo, Nosratola D Vaziri, Shi-Xing Ma, Wei Su, You-Quan Shang, Ming Gao, Jin-Hua Zhang, Li Zhang, Ying-Yong Zhao, Gang Cao
Targeting Lactobacillus johnsonii to reverse chronic kidney disease. Signal transduction and targeted therapy 9 (1) (2024)
Hua Miao, Fei Liu, Yan-Ni Wang, Xiao-Yong Yu, Shougang Zhuang, Yan Guo, Nosratola D Vaziri, Shi-Xing Ma, Wei Su, You-Quan Shang, Ming Gao, Jin-Hua Zhang, Li Zhang, Ying-Yong Zhao, Gang Cao
Targeting Lactobacillus johnsonii to reverse chronic kidney disease. Signal transduction and targeted therapy 9 (1) (2024)
Hua Miao, Fei Liu, Yan-Ni Wang, Xiao-Yong Yu, Shougang Zhuang, Yan Guo, Nosratola D Vaziri, Shi-Xing Ma, Wei Su, You-Quan Shang, Ming Gao, Jin-Hua Zhang, Li Zhang, Ying-Yong Zhao, Gang Cao
Targeting Lactobacillus johnsonii to reverse chronic kidney disease. Signal transduction and targeted therapy 9 (1) (2024)
Hua Miao, Yan-Ni Wang, Xiao-Yong Yu, Liang Zou, Yan Guo, Wei Su, Fei Liu, Gang Cao, Ying-Yong Zhao
Lactobacillus species ameliorate membranous nephropathy through inhibiting aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites. British journal of pharmacology (2023)
Fengyao Yan, Dan-Qian Chen, Jijun Tang, Ying-Yong Zhao, Yan Guo
Serum Metabolites Associated with Blood Pressure in Chronic Kidney Disease Patients. Metabolites 12 (4) (2022)
Yan-Ni Wang, He-He Hu, Dan-Dan Zhang, Xia-Qing Wu, Jian-Ling Liu, Yan Guo, Hua Miao, Ying-Yong Zhao
The Dysregulation of Eicosanoids and Bile Acids Correlates with Impaired Kidney Function and Renal Fibrosis in Chronic Renal Failure. Metabolites 11 (2) (2021)
Hua Miao, Xia-Qing Wu, Yan-Ni Wang, Dan-Qian Chen, Lin Chen, Nosratola D Vaziri, Shougang Zhuang, Yan Guo, Wei Su, Shi-Xing Ma, Huan-Qiao Zhang, You-Quan Shang, Xiao-Yong Yu, Yan-Long Zhao, Jia-Rong Mao, Ming Gao, Jin-Hua Zhang, Jin Zhao, Yuan Zhang, Li Zhang, Ying-Yong Zhao, Gang Cao
1-Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway. British journal of pharmacology (2021)
Jing-Ru Liu, Hua Miao, De-Qiang Deng, Nosratola D Vaziri, Ping Li, Ying-Yong Zhao
Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation. Cellular and molecular life sciences : CMLS 78 (3) (2020)
Hua Miao, Gang Cao, Xia-Qing Wu, Yuan-Yuan Chen, Dan-Qian Chen, Lin Chen, Nosratola D Vaziri, Ya-Long Feng, Wei Su, Yi Gao, Shougang Zhuang, Xiao-Yong Yu, Li Zhang, Yan Guo, Ying-Yong Zhao
Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation. British journal of pharmacology 177 (15) (2020)
Dan-Qian Chen, Xia-Qing Wu, Lin Chen, He-He Hu, Yan-Ni Wang, Ying-Yong Zhao
Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis via modulating protein stability of β-catenin and β-catenin-mediated transcription. Therapeutic advances in chronic disease 11 (2020)
Hua Chen, Min-Chang Wang, Yuan-Yuan Chen, Lin Chen, Yan-Ni Wang, Nosratola D Vaziri, Hua Miao, Ying-Yong Zhao
Alisol B 23-acetate attenuates CKD progression by regulating the renin-angiotensin system and gut-kidney axis. Therapeutic advances in chronic disease 11 (2020)
Hui Yu, Shilin Zhao, Scott A Ness, Huining Kang, Quanhu Shen, David C Samuels, Olufunmilola Oyebamiji, Ying-Yong Zhao, Yan Guo
Non-canonical RNA-DNA differences and other human genomic features are enriched within very short tandem repeats. PLoS computational biology 16 (6) (2020)
Yuan-Yuan Chen, Min-Chang Wang, Yan-Ni Wang, He-He Hu, Qing-Quan Liu, Hai-Jing Liu, Ying-Yong Zhao
Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy. Biomarker research 8 (2020)
Liuyi Dang, Jiechen Shen, Ting Zhao, Fei Zhao, Li Jia, Bojing Zhu, Chen Ma, Danqian Chen, Ying-Yong Zhao, Shisheng Sun
Recognition of Bisecting N-Glycans on Intact Glycopeptides by Two Characteristic Ions in Tandem Mass Spectra. Analytical chemistry 91 (9) (2019)
Hui Zhao, Lin Chen, Tian Yang, Ya-Long Feng, Nosratola D Vaziri, Bao-Li Liu, Qing-Quan Liu, Yan Guo, Ying-Yong Zhao
Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma. Journal of translational medicine 17 (1) (2019)
Bo Ye, Jianxin Shi, Huining Kang, Olufunmilola Oyebamiji, Deirdre A Hill, Hui Yu, Scott A Ness, Fei Ye, Jie Ping, Jiapeng He, Jeremy S Edwards, Ying-Yong Zhao, Yan Guo
Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA. RNA biology 17 (11) (2019)
Ya-Long Feng, Gang Cao, Dan-Qian Chen, Nosratola D Vaziri, Lin Chen, Jun Zhang, Ming Wang, Yan Guo, Ying-Yong Zhao
Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Cellular and molecular life sciences : CMLS 76 (24) (2019)
Yuan-Yuan Chen, Dan-Qian Chen, Lin Chen, Jing-Ru Liu, Nosratola D Vaziri, Yan Guo, Ying-Yong Zhao
Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. Journal of translational medicine 17 (1) (2019)
Dan-Qian Chen, Gang Cao, Hua Chen, Christos P Argyopoulos, Hui Yu, Wei Su, Lin Chen, David C Samuels, Shougang Zhuang, George P Bayliss, Shilin Zhao, Xiao-Yong Yu, Nosratola D Vaziri, Ming Wang, Dan Liu, Jia-Rong Mao, Shi-Xing Ma, Jin Zhao, Yuan Zhang, You-Quan Shang, Huining Kang, Fei Ye, Xiao-Hong Cheng, Xiang-Ri Li, Li Zhang, Mei-Xia Meng, Yan Guo, Ying-Yong Zhao
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan. Nature communications 10 (1) (2019)
Lin Chen, Dan-Qian Chen, Jing-Ru Liu, Jun Zhang, Nosratola D Vaziri, Shougang Zhuang, Hua Chen, Ya-Long Feng, Yan Guo, Ying-Yong Zhao
Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis. Experimental & molecular medicine 51 (3) (2019)
Dan-Qian Chen, Gang Cao, Hui Zhao, Lin Chen, Tian Yang, Ming Wang, Nosratola D Vaziri, Yan Guo, Ying-Yong Zhao
Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum. Therapeutic advances in chronic disease 10 (2019)
Ya-Long Feng, Dan-Qian Chen, Nosratola D Vaziri, Yan Guo, Ying-Yong Zhao
Small molecule inhibitors of epithelial-mesenchymal transition for the treatment of cancer and fibrosis. Medicinal research reviews 40 (1) (2019)
Tian Yang, Ya-Long Feng, Lin Chen, Nosratola D Vaziri, Ying-Yong Zhao
Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor. Critical reviews in toxicology 49 (5) (2019)
Yan Guo, Hui Yu, Jing Wang, Quanhu Sheng, Shilin Zhao, Ying-Yong Zhao, Brian D Lehmann
The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer. Genes 9 (1) (2018)
Ming Wang, Dan-Qian Chen, Lin Chen, Gang Cao, Hui Zhao, Dan Liu, Nosratola D Vaziri, Yan Guo, Ying-Yong Zhao
Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis. British journal of pharmacology 175 (13) (2018)
Ming Wang, Dan-Qian Chen, Lin Chen, Dan Liu, Hui Zhao, Zhi-Hao Zhang, Nosratola D Vaziri, Yan Guo, Ying-Yong Zhao, Gang Cao
Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling. Journal of agricultural and food chemistry 66 (8) (2018)
Hua Chen, Lin Chen, Dan Liu, Dan-Qian Chen, Nosratola D Vaziri, Xiao-Yong Yu, Li Zhang, Wei Su, Xu Bai, Ying-Yong Zhao
Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism. Journal of proteome research 16 (4) (2017)

Ying-Yong Zhao.css-eqlu8i{font-size:small;padding-left:4px;} (Yingyong Zhao)

Publication Activity (10 Years)

Top Topics

Top Venues

Ying-Yong Zhao (Yingyong Zhao)